secwatch.observer — SEC 8-K summary
======================================

Issuer:     ProMIS Neurosciences Inc. (PMN)
CIK:        0001374339
Form:       8-K
Filed at:   2024-07-26T23:59:59+00:00
Accession:  0001558370-24-010224
Event type: other_material
Sentiment:  neutral
Materiality: 0.75
Item codes: 1.01, 3.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ProMIS Neurosciences raises $30.3M in PIPE financing with warrants for up to $92.4M more
--------------------------------------------------------------------------------

- Gross proceeds of $30.3M from sale of 9,757,669 common units at $2.15/unit and 4,371,027 pre-funded units at $2.14/unit.
- Each unit includes one common share (or pre-funded warrant) and Tranche A, B, and C warrants with exercise prices of $2.02, $2.02, and $2.50, respectively.
- Tranche A/B warrants subject to shareholder approval and expire upon 6-month or 12-month PMN310 data announcement; Tranche C expires July 31, 2029.
- Proceeds to advance clinical development of PMN310, an antibody for Alzheimer's disease, plus working capital and general expenses.
- All outstanding Series 2 Preferred Shares automatically convert into 1,166,667 common shares upon closing of this offering.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1374339/000155837024010224/0001558370-24-010224-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1374339/000155837024010224/pmn-20240726x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-24-010224

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer